
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SDF-2 CRISPR/Cas9 KO Plasmid (h) | sc-404598 | 20 µg | $397.00 | |||
SDF-2 HDR Plasmid (h) | sc-404598-HDR | 20 µg | $445.00 |
SDF2 encodes stromal cell derived factor 2 (SDF-2), an endoplasmic reticulum–localized protein implicated in ER proteostasis and quality control during secretory protein folding. SDF-2 is linked to unfolded protein response signaling and ER-associated processing pathways that maintain cellular homeostasis under proteotoxic stress. Altered ER stress handling and secretory pathway dysfunction are relevant to mechanisms studied in cancer biology, metabolic stress, and neurodegeneration, where adaptive UPR signaling can influence survival and differentiation programs. As a result, SDF2 is frequently examined in contexts involving ER stress responses, protein maturation, and trafficking.
SDF-2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SDF2 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the SDF2 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, SDF-2 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined SDF2 target site.
When co-transfected with SDF-2 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the SDF2 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.